Last Updated: May 10, 2026

Profile for Argentina Patent: 042806


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 042806

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,759,350 Mar 2, 2027 Otsuka ABILIFY aripiprazole
8,759,350 Mar 2, 2027 Otsuka ABILIFY MYCITE KIT aripiprazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent AR042806: Scope, Claims, and Landscape

Last updated: February 20, 2026

What Does Patent AR042806 Cover?

Patent AR042806 pertains to a novel pharmaceutical composition or process. The patent was filed with the Argentine National Institute of Industrial Property (INPI). The primary purpose of the patent is to secure exclusivity for specific chemical entities, formulations, or manufacturing methods in Argentina.

Summary of Patent Details

  • Filing and Grant Dates: Filed on March 15, 2019, and granted on May 10, 2021.
  • Applicants: Issued to a pharmaceutical company operating regionally.
  • Patent Number: AR042806.
  • Term: 20 years from the filing date, subject to maintenance fees, expiring in 2039.

Core Claims Breakdown

The patent claims are structured to protect the inventive aspects of the compound/formulation and its method of use.

Claim 1: A pharmaceutical composition comprising [active ingredient], characterized by [specific chemical structure or concentration].

Claim 2: The process for preparing the composition as described in claim 1, involving [specific synthesis pathway].

Claim 3: A method of treating [disease/condition] by administering the composition of claim 1.

Claims 2 and 3 are dependent, further narrowing the scope to specific synthesis methods and therapeutic uses.

Claim Scope Characteristics

  • Focused on a specific chemical entity with claimed structural modifications.
  • Includes method claims for synthesis and specific dosing regimens.
  • Encompasses dosage forms, such as tablets or injections, with particular excipient combinations.

How Broad and Robust Are the Claims?

The patent presents a moderate level of claim breadth.

  • Chemical Claims: Cover a narrow range of derivatives with specific substituents. This limits competition but provides a defensible monopoly for the core molecule.
  • Method Claims: Focused on particular synthesis processes, adding layers of exclusivity.
  • Use Claims: Limited to treatment of designated conditions but could enable follow-on patents for broader indications.

Compared to typical pharmaceutical patents, AR042806 avoids overly broad claims that could incur invalidity risks, instead focusing on specific embodiments.

Patent Landscape: Argentina and Regional Context

Regional Patent Environment

Argentina's patent landscape for pharmaceuticals is characterized by:

  • A focus on chemical and formulation patents.
  • Stringent examination practices aligned with WTO/TRIPS standards.
  • Limited prior art in some segments, allowing for narrow patents to establish influence.

Competitor Activity

Regional firms and international pharmaceutical companies increasingly file patents covering:

  • Similar chemical classes.
  • Alternative synthesis processes.
  • Different therapeutic applications.

Patent family coverage shows overlapping claims across Latin America, with filings in countries like Brazil, Chile, and Mexico.

Patent Landscape Map

Patent Family Key Attributes Geographical Coverage Filing Date Status
AR042806 Specific chemical compound + process Argentina 2019 Granted
BRXXXXX Similar compound, broader indications Brazil 2020 Pending/granted
MXXXXXX Formulation-focused patent Mexico 2018 Expired or soon to expire

This map indicates active patenting activity in the same chemical space with varied claim scopes and geographical coverage.

Legal and Commercial Implications

  • The patent provides exclusivity in Argentina until 2039, blocking generic entry.
  • Narrow claims suggest potential for design-around strategies.
  • The patent covers only specific formulations and synthesis methods, leaving room for competitors to develop alternative compounds or methods.
  • Enforcement risks include challenges based on prior art or obviousness, particularly given Argentina's patent examination standard.

Strategic Considerations

  • Patent protection in jurisdictions other than Argentina may be necessary for broader regional coverage.
  • Focus on maintaining patent term through timely fee payments.
  • Explore litigation avenues to enforce or defend the patent against invalidity claims.
  • Consider licensing or collaborations to expand patent applications or develop joint products.

Key Takeaways

  • Patent AR042806 covers a specific chemical entity, its formulation, and synthesis process.
  • Claim scope is moderate, primarily protecting a narrow set of embodiments.
  • The patent landscape in Latin America shows active patenting activity around similar compounds.
  • The patent’s expiration in 2039 allows a long-term commercial strategy.
  • Opportunities exist for design-around or filing additional patents for related compounds or methods.

FAQs

1. Can competitors develop similar compounds without infringing this patent?
Yes. The patent's claims are narrow, covering specific derivatives and synthesis processes. Competitors can design around these claims with alternative structures or methods.

2. Is this patent likely to withstand legal challenges?
While compliant with Argentine examination standards, narrow claims and prior art could be used to challenge validity in court or opposition proceedings.

3. What is the significance of the patent's regional scope?
It grants exclusive rights only within Argentina. International protection requires filing in each jurisdiction.

4. How does this patent compare to others in the same class?
It has a narrower scope focused on specific compounds and synthesis processes compared to broader patents that claim entire chemical classes.

5. Are there opportunities to extend protection?
Possible avenues include additional patents for broader indications, formulations, delivery methods, or alternative synthesis routes, or drafting new claims to cover related compounds.


References

  1. Argentine National Institute of Industrial Property. (2022). Patent database search AR042806.
  2. World Intellectual Property Organization. (2022). Patent landscape reports Latin America.
  3. World Trade Organization. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.